Breast Neoplasms: all 12,820 studies
Page 119 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Exercise Intervention in Women With Metastatic Breast CancerCompletedNCT00405782Not applicable
- Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.CompletedNCT00405678Phase 1/2
- ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerStatus unknownNCT00404404Phase 2
- Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast CarcinomaTerminatedNCT00403988Phase 2
- Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00403182Phase 3
- APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast CancerStatus unknownNCT00402519Phase 3
- HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast CancerCompletedNCT00401427Phase 2
- A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00399321
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
- Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast CancerStatus unknownNCT00398437Not applicable
- Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerWithdrawnNCT00397761Phase 2/3
- BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWithdrawnNCT00397501Phase 1/2
- Hydralazine and Valproate Added to Chemotherapy for Breast CancerTerminatedNCT00395655Phase 2
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and ImmunogenicityActive, not recruitingNCT00393783Phase 1
- A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer TreatmentCompletedNCT00393497Phase 1
- The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method ApproachCompletedNCT00393406
- Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast CancerCompletedNCT00393341
- Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]CompletedNCT00393172Phase 2/3
- Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving SurgeryCompletedNCT00392184Phase 2
- Use of Hair to Diagnose Breast CancerStatus unknownNCT00390377Phase 2
- Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer PatientsStatus unknownNCT00390169Phase 3
- Radiation Induced Atherosclerosis in Breast Cancer PatientsStatus unknownNCT00388713
- Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in SituCompletedNCT00388115Not applicable
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast CancerCompletedNCT00387907Phase 2
- XRP9881 in Combination With Trastuzumab in Metastatic Breast CancerCompletedNCT00386685Phase 2
- Spousal Relationships and Pain in Metastatic Breast CancerCompletedNCT00386620
- Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCompletedNCT00386087Phase 2
- Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsCompletedNCT00385177Phase 1
- Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2CompletedNCT00383604
- Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer DevelopmentCompletedNCT00381927
- Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By SurgeryCompletedNCT00381901Phase 3
- Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer PatientsStatus unknownNCT00381368Phase 2
- Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast CancerWithdrawnNCT00380835Phase 2
- Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast CancerCompletedNCT00379509Phase 1
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
- Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot StudyStatus unknownNCT00378638Phase 2
- A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast CancerCompletedNCT00378313Phase 2
- Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast CancerTerminatedNCT00377780Phase 2
- Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast CancerCompletedNCT00377559Phase 2
- A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income WomenCompletedNCT00376909Phase 2
- Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving LetrozoleCompletedNCT00376740Phase 3
- Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By SurgeryCompletedNCT00373191
- MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast CancerWithdrawnNCT00373152Phase 2
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone LesionsTerminatedNCT00372710Phase 3
- Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast CancerCompletedNCT00372476Phase 4
- GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast CancerCompletedNCT00371488Phase 1
- Chlorhydrate of Ropivacaine and Breast Cancer SurgeryCompletedNCT00370240Phase 4
- Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98CompletedNCT00369850Phase 3
- Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid TumorsCompletedNCT00369109
- Using Diagnostic Tools to Stage Breast CancerActive, not recruitingNCT00367666Not applicable
- Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.CompletedNCT00367471Phase 1
- Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast CancerStatus unknownNCT00367250Phase 1
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- Development of Gourmet Healthy Cooking Workshop for Cancer PatientsWithdrawnNCT00364975Not applicable
- Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast CancerCompletedNCT00364754Phase 1
- Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast CancerCompletedNCT00364195Phase 2
- Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2CompletedNCT00363012Not applicable
- PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast CancerCompletedNCT00362973
- Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph NodesCompletedNCT00360152Early Phase 1
- Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast CancerCompletedNCT00359190Phase 1
- Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE StudyCompletedNCT00359060Phase 3
- Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerTerminatedNCT00358098
- Evaluation of Two New Medical Instruments Dedicated to the Sentinel Lymph Node Technique in Case of Breast CancerCompletedNCT00357487Not applicable
- A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerTerminatedNCT00356681Phase 2
- Evaluating Patient Information PrescriptionsCompletedNCT00355381Phase 2
- A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer PatientsCompletedNCT00355316Not applicable
- Phase I Study of Aprotinin in Advanced Breast CancerTerminatedNCT00354900Phase 1
- Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical TrialCompletedNCT00354302Phase 3
- Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast CarcinomaStatus unknownNCT00353717Phase 1/2
- Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast CancerTerminatedNCT00352872
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast CancerTerminatedNCT00351858Phase 2
- IMP321 Plus First-line Paclitaxel in Metastatic Breast CarcinomaCompletedNCT00349934Phase 1
- AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT00348699Phase 1
- BC-DAISY: A Breast Cancer Decision Aid SystemCompletedNCT00347568Not applicable
- Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast CancerTerminatedNCT00346229Phase 1
- Pilot Study of Inflammatory Breast Cancer in Egypt and TunisiaCompletedNCT00344071
- Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted TherapyWithdrawnNCT00343759Phase 2
- Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98CompletedNCT00343616Phase 3
- Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose WeightCompletedNCT00343434Not applicable
- Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast CancerCompletedNCT00343109Phase 2
- Studying Normal Breast Tissue and Cancer RiskCompletedNCT00341692
- Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsCompletedNCT00341458
- Breast Cancer, Breast Disease, and PesticidesCompletedNCT00341315
- Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) StudyCompletedNCT00341159
- Establishing an Inflammatory Breast Cancer RegistryCompletedNCT00340158
- Markers for Breast CancerCompletedNCT00339248
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerApproved for marketingNCT00338247
- A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT00337649Phase 1/2
- Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast CancerCompletedNCT00337233Not applicable
- Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly WomenStatus unknownNCT00337064Phase 1/2
- Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast CancerCompletedNCT00336791Phase 3
- Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy VolunteersCompletedNCT00336102
- Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer SurvivorsStatus unknownNCT00336089Not applicable
- Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsCompletedNCT00335491Not applicable
- Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerCompletedNCT00334139Phase 4
- Letrozole in Metastatic Breast Cancer in Combination With ChemotherapyCompletedNCT00333047Phase 2/3
- Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast CancerCompletedNCT00332852Phase 3